I want to set an example for the country to replicate, that the industries in Maharashtra can fully operate with complete COVID-appropriate behaviour & protocols: Uddhav Thackeray

CMO Maharashtra:

This evening, Maharashtra CM Uddhav Thackeray interacted virtually with leading industrialists and entrepreneurs.

He made the following points in his address;

I want to set an example for the country to replicate that the industries in Maharashtra can fully operate with complete COVID-appropriate behaviour & protocols. We neither want a lockdown nor a knockdown. So, keep following all health protocols.

The new set of criteria & levels under Break The Chain is a calculated risk. Hence, I request you to please take care.

We have not done away with the restrictions in a hurry. Keep detailed health records of workers & migrant labourers from other states working in Maharashtra.

Please ensure that they do not spread COVID while returning to their States or while coming back here. Maintain the records of their family members as well. After these workers return from other States, keep them in isolation, conduct regular health checkups.

Monsoons are here. Communicable diseases may increase. Please ensure that your workers and employees abide by all health protocols. Take care to ensure that there is no stagnant water at construction sites as this may lead to diseases like dengue & malaria.

Imbibe the use of masks. Incorporate systems in a way that if there is an onset of the third wave and a lockdown must be imposed, the day-to-day working of industries and their production must not be affected.

Like we created field hospitals and health facilities, the industries must develop temporary facilities in their premises for workers and employees.

Send us your views on the issue of holding the Class 10th & 12th board exams in 2021: Mamata Banerjee

Our children’s future is my greatest priority. To this regard, we have formed an expert committee to decide over holding the Class 10th & 12th board exams in 2021.

We are also inviting views & opinion from parents, general public, sector experts, civil society & students.

I request each one of you to send us your feedback on the issue by e-mailing us on following addresses by June 7th, 2021, 2 PM.

– pbssm.spo@gmail.com
-commissionerschooleducation@gmail.com
-wbssed@gmail.com

Your suggestions will be valuable to us.

Mamata Banerjee – Chief Minister, West Bengal

CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19: Ministry of Science & Technology

Ministry of Science & Technology:

CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment of Covid-19.

The trial is a multi-centric, phase-II, randomized, open label clinical study to evaluate efficacy, safety and tolerability of Niclosamide for the treatment of hospitalized Covid-19 patients.

Niclosamide has been extensively used in past for treatment of tapeworm’s infection in adults as well as children. The safety profile of this drug has been tested over time and has been found safe for human consumption at different dose levels.        

Dr Shekhar C Mande, Director General, CSIR expressed his happiness over the SEC recommendations to conduct this Phase II clinical trial using Niclosamide, which is generic, affordable drug and easily available in India and therefore can be made available to our population. Dr Ram Vishwakarma, Advisor to DG-CSIR pointed out that

a) in a screen to identify drugs that can inhibit syncytia formation, Niclosamide was identified as a promising repurposed drug by research group from King’s College, London, who collaborated in this project. The syncytia or fused cells observed in the lungs of patients with COVID-19 probably results from the fusogenic activity of the SARS-CoV-2 spike protein and Niclosamide can inhibit syncytia formation.

b) Independently, collaborative research between CSIR-IIIM, Jammu and NCBS, Bangalore has recently demonstrated that Niclosamide is also a potential SARS-CoV2 entry inhibitor blocking the viral entry through pH dependent endocytic pathway.

Given these two independent experimental studies, Niclosamide has now emerged as a promising drug candidate for clinical trial in Covid-19 patients.

Dr Srivari Chandrashekhar, Director CSIR-IICT Hyderabad, highlighted that the Active Pharmaceutical Ingredient (API) is being made by Laxai Life Sciences based on improved technology developed at IICT and the lab is a partner in this important clinical trial which could provide cost effective therapeutic options for patients if trial is successful.           

Dr Ram Upadhayaya, CEO, Laxai informed, that realizing the potential of Niclosamide, efforts were initiated last year itself to undertake clinical trials. Having received approval from drug regulator, the clinical trial has been initiated this week at different sites and is expected that the trial will be completed within 8-12 weeks.

Based on successful clinical evidence generated during clinical trials in Indian studies, emergency use authorization may be sought so that more treatment options are available to COVID-19 patients.

The Daily COVID19 Positivity rate stands at 5.62% today

Ministry of Health:

India has reported 1,14,460 New Cases in the last 24 hours. This is the lowest in the last two months. 

The country has recorded less than 2 lakh Daily New Cases for 10 continuous days now.

This is a result of collaborative and sustained efforts by the Centre and States/UTs following the “whole of Government” approach.

India has been witnessing a continuous fall in the active cases. The country’s Active Caseload has dipped below 15 lakh mark; stands at 14,77,799 today. The Caseload is below 20 lakhs for six successive days.

A net decline of 77,449 is witnessed in the last 24 hours and active cases are now only 5.13% of the country’s total Positive Cases.

With more people recovering from COVID19 infection, India’s Daily Recoveries continue to outnumber the Daily New Cases for the 24th consecutive day. 1,89,232 recoveries were registered in the last 24 hours.

74,772 more recoveries were reported during the last 24 hours as compared to the daily new cases.

Out of the people infected since beginning of the pandemic 2,69,84,781 people have already recovered from COVID-19.  This constitutes an overall recovery rate of 93.67%, which is showing an increasing trend.

A total of 20,36,311 tests were conducted in the last 24 hours in the country and cumulatively India has conducted over 36.4 crore (36,47,46,522) tests so far.

While on one side testing has been enhanced across the country, a continued decline in weekly case positivity is noticed. Weekly Positivity Rate is currently at 6.54% while the Daily Positivity rate stands at 5.62% today. It has remained less than 10% for 13 consecutive days now.

In another significant achievement, the cumulative number of COVID-19 vaccine doses administered in the country has exceeded 23 crore. 23.13 Cr vaccine doses have been administered under the Nationwide Vaccination Drive. 33,53,539 vaccine doses were administered in the last 24 hours.

A total of 23,13,22,417 vaccine doses have been administered through 32,42,503 sessions, as per the provisional report till 7 am today.

Personally visited Vandalur Zoo, Chennai, on coming to know that Lions were infected with COVID19: MK Stalin

Personally visited the Arignar Anna Zoological Park, Vandalur, Chennai, on coming to know that Lions were infected with COVID19

I urged the authorities to take all necessary measures to ensure that the infected Lions recover fully and take preventive measures to stop the infection from spreading.

MK Stalin – Chief Minister, Tamil Nadu

The BMC and MTDC are working on creating a 10.2 km walking/cycling eco friendly track: Aaditya Thackeray

This evening I visited the Powai Lake where along on my humble request, the BMC and MTDC are working on creating a 10.2 km walking/ cycling eco friendly track with the natural contours and all flora fauna being maintained as is.

As we progress with the track, it will not just open up a natural urban space to citizens and tourists alike, but also help us interact with nature better.

The Powai lake is a gem of our city with its beautiful surroundings. Every aspect of this track will be eco friendly

Aaditya Thackeray – Minister, Maharashtra Govt.

A view from inside the cabin of the 5th Oxygen Express to Assam: Dr Jitendra Singh

A view from inside the cabin of the 5th Oxygen Express to Assam carrying 80 MT of Liquid Medical Oxygen from Jharkhand.

Green Corridor is created to clear obstructions to reach the destination in the minimum possible time.

Dr Jitendra Singh – Union Minister

Sri Sri at Sunrise

Meditation is accepting this moment, and living every moment totally with depth :
@SriSri